2019/2020

  1. ICD-10-CM Codes
    2. ›
  2. C00-D49 Neoplasms
    3. ›
  3. D00-D09 In situ neoplasms
    4. ›
  4. D02- Carcinoma in situ of middle ear and respiratory system
    5. ›

2020 ICD-10-CM Diagnosis Code D02.0

Carcinoma in situ of larynx

    2016 2017 2018 2019 2020 Billable/Specific Code
  • D02.0 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2020 edition of ICD-10-CM D02.0 became effective on October 1, 2019.
  • This is the American ICD-10-CM version of D02.0 - other international versions of ICD-10 D02.0 may differ.
Applicable To
  • Carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect
  • Carcinoma in situ of epiglottis (suprahyoid portion)
Type 1 Excludes
Type 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D02.0. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
  • carcinoma in situ of aryepiglottic fold or interarytenoid fold NOS (
    ICD-10-CM Diagnosis Code D00.08

    Carcinoma in situ of pharynx

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold NOS
    • Carcinoma in situ of hypopharyngeal aspect of aryepiglottic fold
    • Carcinoma in situ of marginal zone of aryepiglottic fold
    D00.08
    )
  • carcinoma in situ of hypopharyngeal aspect (
    ICD-10-CM Diagnosis Code D00.08

    Carcinoma in situ of pharynx

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold NOS
    • Carcinoma in situ of hypopharyngeal aspect of aryepiglottic fold
    • Carcinoma in situ of marginal zone of aryepiglottic fold
    D00.08
    )
  • carcinoma in situ of marginal zone (
    ICD-10-CM Diagnosis Code D00.08

    Carcinoma in situ of pharynx

      2016 2017 2018 2019 2020 Billable/Specific Code
    Applicable To
    • Carcinoma in situ of aryepiglottic fold NOS
    • Carcinoma in situ of hypopharyngeal aspect of aryepiglottic fold
    • Carcinoma in situ of marginal zone of aryepiglottic fold
    D00.08
    )
The following code(s) above D02.0 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
  • Applicable To annotations, or
  • Code Also annotations, or
  • Code First annotations, or
  • Excludes1 annotations, or
  • Excludes2 annotations, or
  • Includes annotations, or
  • Note annotations, or
  • Use Additional annotations
that may be applicable to D02.0:
  • C00-D49
    2020 ICD-10-CM Range C00-D49

    Neoplasms

    Note
    • Functional activity
    • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
    • Morphology [Histology]
    • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
    • Primary malignant neoplasms overlapping site boundaries
    • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
    • Malignant neoplasm of ectopic tissue
    • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
    Neoplasms
  • D00-D09
    2020 ICD-10-CM Range D00-D09

    In situ neoplasms

    Includes
    • Bowen's disease
    • erythroplasia
    • grade III intraepithelial neoplasia
    • Queyrat's erythroplasia
    In situ neoplasms
  • D02
    ICD-10-CM Diagnosis Code D02

    Carcinoma in situ of middle ear and respiratory system

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    Carcinoma in situ of middle ear and respiratory system
Approximate Synonyms
  • Cancer in situ of larynx
Clinical Information
  • Abnormal cells are found in the lining of the larynx. These abnormal cells may become cancer and spread into nearby normal tissue.
  • Stage 0 includes: tis, n0, m0. Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th and 7th eds.)
  • Stage 0 includes: tis, n0, m0. Tis: carcinoma in situ. N0: no regional lymph node metastasis. M0: no distant metastasis. (ajcc 6th ed.)
ICD-10-CM D02.0 is grouped within Diagnostic Related Group(s) (MS-DRG v37.0):
  • 011 Tracheostomy for face, mouth & neck diagnoses or laryngectomy with mcc
  • 012 Tracheostomy for face, mouth & neck diagnoses or laryngectomy with cc
  • 013 Tracheostomy for face, mouth & neck diagnoses or laryngectomy without cc/mcc
  • 146 Ear, nose, mouth and throat malignancy with mcc
  • 147 Ear, nose, mouth and throat malignancy with cc
  • 148 Ear, nose, mouth and throat malignancy without cc/mcc

Convert D02.0 to ICD-9-CM

Code History
  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
Code annotations containing back-references to D02.0:
  • Type 1 Excludes: D00.0
    , D00.0
    , D00.0
    ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
    ICD-10-CM Diagnosis Code D00.0

    Carcinoma in situ of lip, oral cavity and pharynx

      2016 2017 2018 2019 2020 Non-Billable/Non-Specific Code
    Type 1 Excludes
    • carcinoma in situ of aryepiglottic fold or interarytenoid fold, laryngeal aspect (D02.0)
    • carcinoma in situ of epiglottis NOS (D02.0)
    • carcinoma in situ of epiglottis suprahyoid portion (D02.0)
    • carcinoma in situ of skin of lip (D03.0, D04.0)
    Use Additional
    • code to identify:
    • exposure to environmental tobacco smoke (Z77.22)
    • exposure to tobacco smoke in the perinatal period (P96.81)
    • history of tobacco dependence (Z87.891)
    • occupational exposure to environmental tobacco smoke (Z57.31)
    • tobacco dependence (F17.-)
    • tobacco use (Z72.0)
ICD-10-CM Codes Adjacent To D02.0
D01.1 Carcinoma in situ of rectosigmoid junction
D01.2 Carcinoma in situ of rectum
D01.3 Carcinoma in situ of anus and anal canal
D01.4 Carcinoma in situ of other and unspecified parts of intestine
D01.40 Carcinoma in situ of unspecified part of intestine
D01.49 Carcinoma in situ of other parts of intestine
D01.5 Carcinoma in situ of liver, gallbladder and bile ducts
D01.7 Carcinoma in situ of other specified digestive organs
D01.9 Carcinoma in situ of digestive organ, unspecified
D02 Carcinoma in situ of middle ear and respiratory system
D02.0 Carcinoma in situ of larynx
D02.1 Carcinoma in situ of trachea
D02.2 Carcinoma in situ of bronchus and lung
D02.20 Carcinoma in situ of unspecified bronchus and lung
D02.21 Carcinoma in situ of right bronchus and lung
D02.22 Carcinoma in situ of left bronchus and lung
D02.3 Carcinoma in situ of other parts of respiratory system
D02.4 Carcinoma in situ of respiratory system, unspecified
D03 Melanoma in situ
D03.0 Melanoma in situ of lip
D03.1 Melanoma in situ of eyelid, including canthus

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Advertise with Us | License ICD10 Data

Copyright © 2018 | ICD10data.com